Breyer Capital
7 people tracked
Investment thesis
Breyer Capital invests at the intersection of scientific discovery, clinical necessity, and institutional transformation in healthcare. The firm targets breakthrough biomedical technologies driven by computation, precision medicine, and preventive systems. Its investment philosophy centers on backing founders who rearchitect healthcare through AI-first diagnostics, programmable medicines, data infrastructure, new financial systems, clinician software, and novel care delivery models. The firm takes a long-term, early-stage approach, partnering deeply with entrepreneurs who pursue science-driven solutions, build full-stack systems across discovery and delivery, and establish new standards rather than optimize existing structures.
Source: firm website, verified Jul 17, 2026.
Team · 7 people
from the firm's websiteDaniel Breyer is a Partner at Breyer Capital who has led investments in companies including Headspace, Grammarly, Epic Games, Stash, Zepto, and OnyxOdds. He co-founded Flare, a communications platform unifying messaging, events, and communities across networks, and is an author of literary fiction.
Morgan leads healthcare and life sciences investing at Breyer Capital, with expertise spanning software, services, therapeutics, diagnostics, and AI. Prior to joining, he spent nearly a decade at Bessemer Venture Partners leading healthcare investments in companies like Abridge and Hinge Health, and is currently pursuing a clinical genetics fellowship at Harvard/Boston Children's while publishing research on clinical AI and genetic medicine.
Bret is a physician-scientist and drug developer with expertise in drug discovery, clinical development, and translational medicine. Since 2019, he has been at Alnylam Pharmaceuticals where he co-invented CNS-targeted RNAi therapeutics, and he leads Translational Medicine Solutions, an advisory firm at the intersection of healthcare, technology, and venture capital.
Samuel Palmisano served as Chairman, President, and CEO of IBM from 2003 to 2011, driving record financial results and transforming the company into a globally integrated enterprise. After IBM, he became Chairman of the Center for Global Enterprise, a nonprofit research institution focused on global business practices and economic trends, and frequently co-invests alongside Breyer Capital.
Leo has 18 years of experience developing and commercializing advanced machine learning, AI, computer vision, and digital health technologies. As former CEO of Paige, he led the company to FDA approval for the first AI product in pathology, and currently serves as founder and CEO of Breyer Capital-backed Jona Health.
Investments · 60 tracked
- 100 Thieves
- 21st Century Fox
- Alt.xyz
- Ansible Health
- Artera
- Artsy
- Atropos Health
- Bestow
- Biocogniv
- C3.ai
- Cadre
- Chia
- Circle
- Cleerly
- ClosedLoop AI
- Credijusto
- CTRL-Labs
- Datalogix
- DISCO
- Dynamic
- Earli
- Edo
- Elysium Health
- Enable Medicine
- Epic Games
- Etsy
- Everly Health
- Fable
- FIGS
- Flare
- Form Bio
- Genies
- Glass Health
- GOLF+
- Grammarly
- Headspace
- High Fidelity
- Homeward
- Huspy
- Iterative Scopes
- Lean
- Legendary
- Levels
- Lyra Health
- Marvel
- Meta / Facebook
- Metatheory
- mPharma
- Nearside
- Neo
- Nesto
- Network Bio
- NeuraLight
- Niantic
- OM1
- Open Evidence
- Oscar Health
- Parallel Finance
- PostEra
- Prosper
Frequently asked questions
- What sectors does Breyer Capital focus on?
- Breyer Capital focuses on AI & Machine Learning, Biotech, Data & Infrastructure, Digital Health, Healthtech, Medical Devices.
Similar investors
A deep technology venture capital firm investing in companies solving major global challenges across climate change, human health, defense, security, space, and physically intensive industries.
An early-stage venture capital firm focused on identifying and investing in founders across diverse technology and innovation sectors.
EQT Life Sciences, formerly known as LSP, is one of Europe's largest life sciences investors with a 30-year track record. The firm targets innovative companies developing therapeutics, medical devices, diagnostics, and healthtech solutions globally, backed by a team of experienced medical, scientific, and industry professionals.
Cincinnati-based venture capital firm focused on investing in founders tackling complex, urgent problems with novel, defensible technology across multiple industries. The firm emphasizes deep technical expertise, compelling product vision, and large, future-proof markets while maintaining close partnership with portfolio companies.
Hyderabad Angels is an early-stage investment network founded in 2010 that backs Indian founders building category-defining companies at the pre-seed and seed stages. The firm offers flexible capital combined with mentorship and strategic guidance.